MAY 30, 2013 08:00 AM PDT

VITROS® Microslide Technologies / Assays

Speakers
  • Director, Scientific Affairs, Ortho Clinical Diagnostics
    Biography
      John Backus, Ph.D. is Director, Scientific Affairs, Ortho Clinical Diagnostics, Part of the Johnson & Johnson Family of Companies. John has 20 years of experience in the In Vitro Diagnostics (IVD) industry. He has held a variety of scientific / managerial positions at Eastman Kodak, Gen-Probe, Sigma, Veridex, and Ortho Clinical Diagnostics, primarily focused on IVD Assay / Technology Development and Clinical Verification and Validation of diagnostic biomarkers to address significant unmet needs in Metabolic Disease, Cardiovascular Disease, Acute Care, Oncology, Reproductive Health, and Infectious Disease. John led the development of the first FDA-approved intra-operative molecular cancer diagnostic and has 13 issued U.S. patents, primarily related to nucleic acid purification, amplification, and detection technologies. John received his Ph.D. in Biochemistry from the University of Rochester. His thesis research focused on elucidation of the RNA sequence elements required for mammalian apoB mRNA editing by the editosome macromolecular complex.

    Abstract:

    VITROS® Microslides utilize a layered, dry-slide technology that enables separate reaction domains such that each step can be optimized to provide excellent assay performance. Excellent precision and accuracy are achieved through designs that combine multiple discrete layers of spreading, masking, scavenger, and other reagent layers. Dry-slide methods use traditional, well-accepted analytical principals and are traceable to accepted reference methods, so that results are consistent over time and around the world. This presentation will focus on three differentiating features of VITROS® Microslide technology: 1) minimization of paraprotein interference in chemistry assays, 2) direct potentiometric measurement of sodium utilizing a disposable ion selective electrode (ISE), and 3) direct measurement of unconjugated, conjugated, and total bilirubin utilizing reflectance spectrophotometry. All three of these features have been demonstrated to improve the clinical/analytical accuracy of assay results.  


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    NOV 18, 2019 07:00 AM PST
    C.E. CREDITS
    NOV 18, 2019 07:00 AM PST
    DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JUL 30, 2019 10:00 AM PDT
    C.E. CREDITS
    JUL 30, 2019 10:00 AM PDT
    DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
    Loading Comments...
    Show Resources